IA
AVEO

IFP Advisors’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

IFP Advisors’s Portfolio AVEO Stock Details AVEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-77
Closed -$1K – 3795
2018
Q4 		$1K Sell
77
-340
-82% -$7.48K ﹤0.01% 3459
2018
Q3 		$14K Buy
417
+400
+2,353% +$10.3K ﹤0.01% 2682
2018
Q2 		$0 Hold
17
– – ﹤0.01% 4159
2018
Q1 		$0 Hold
17
– – ﹤0.01% 3885
2017
Q4 		$0 Hold
17
– – ﹤0.01% 4246
2017
Q3 		$1K Buy
+17
New +$526 ﹤0.01% 4007

Other funds holding AVEO

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
EWM
Evercore Wealth Management New York $6.36B AUM 20.35% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

IFP Advisors's AVEO Position: Q1 2019 in Review

IFP Advisors sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q1 2019, closing a stake of 77 shares — an estimated $1K sold.

IFP Advisors first reported a position in AVEO in Q3 2017 and held it in 6 quarters. The position peaked at $14K in Q3 2018. 83 funds tracked by Wall St. Rank hold AVEO as of Q1 2019.

  • IFP Advisors reported no remaining AVEO Pharmaceuticals, Inc. position as of Q1 2019 after selling out during the quarter.
  • IFP Advisors sold 77 AVEO Pharmaceuticals, Inc. shares in Q1 2019, an estimated $1K.
  • IFP Advisors first reported a position in AVEO Pharmaceuticals, Inc. in Q3 2017 and held it in 6 quarters.
  • IFP Advisors's AVEO Pharmaceuticals, Inc. position peaked at $14K in Q3 2018.
  • 83 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q1 2019.

Based on IFP Advisors's 13F filing for Q1 2019, filed 15 May 2019.